 | • レポートコード：QYR9ST07767 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ニボルマブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注入4mL、注入10mLに、用途別には、切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、クラシカルホジキンリンパ腫、腎細胞癌、その他にセグメント区分し、ニボルマブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ニボルマブの世界市場概要 ・ニボルマブの製造コスト構成分析 ・ニボルマブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ニボルマブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ニボルマブのセグメント分析（種類別） （注入4mL、注入10mL） ・ニボルマブのセグメント分析（用途別） （切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、クラシカルホジキンリンパ腫、腎細胞癌、その他） ・ニボルマブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Ono Pharmaceutical、Bristol-Myers Squibb） ・ニボルマブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Nivolumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nivolumab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nivolumab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nivolumab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nivolumab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Ono Pharmaceutical
Bristol-Myers Squibb
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Injection 4mL
Injection 10mL
Segment by Application
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Nivolumab
1.1 Definition of Nivolumab
1.2 Nivolumab Segment by Type
1.2.1 Global Nivolumab Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Injection 4mL
1.2.3 Injection 10mL
1.3 Nivolumab Segment by Applications
1.3.1 Global Nivolumab Consumption Comparison by Applications (2014-2025)
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global Nivolumab Overall Market
1.4.1 Global Nivolumab Revenue (2014-2025)
1.4.2 Global Nivolumab Production (2014-2025)
1.4.3 North America Nivolumab Status and Prospect (2014-2025)
1.4.4 Europe Nivolumab Status and Prospect (2014-2025)
1.4.5 China Nivolumab Status and Prospect (2014-2025)
1.4.6 Japan Nivolumab Status and Prospect (2014-2025)
1.4.7 Southeast Asia Nivolumab Status and Prospect (2014-2025)
1.4.8 India Nivolumab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nivolumab
2.3 Manufacturing Process Analysis of Nivolumab
2.4 Industry Chain Structure of Nivolumab
3 Development and Manufacturing Plants Analysis of Nivolumab
3.1 Capacity and Commercial Production Date
3.2 Global Nivolumab Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nivolumab
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Nivolumab Production and Capacity Analysis
4.2 Nivolumab Revenue Analysis
4.3 Nivolumab Price Analysis
4.4 Market Concentration Degree
5 Nivolumab Regional Market Analysis
5.1 Nivolumab Production by Regions
5.1.1 Global Nivolumab Production by Regions
5.1.2 Global Nivolumab Revenue by Regions
5.2 Nivolumab Consumption by Regions
5.3 North America Nivolumab Market Analysis
5.3.1 North America Nivolumab Production
5.3.2 North America Nivolumab Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Nivolumab Import and Export
5.4 Europe Nivolumab Market Analysis
5.4.1 Europe Nivolumab Production
5.4.2 Europe Nivolumab Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Nivolumab Import and Export
5.5 China Nivolumab Market Analysis
5.5.1 China Nivolumab Production
5.5.2 China Nivolumab Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Nivolumab Import and Export
5.6 Japan Nivolumab Market Analysis
5.6.1 Japan Nivolumab Production
5.6.2 Japan Nivolumab Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Nivolumab Import and Export
5.7 Southeast Asia Nivolumab Market Analysis
5.7.1 Southeast Asia Nivolumab Production
5.7.2 Southeast Asia Nivolumab Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Nivolumab Import and Export
5.8 India Nivolumab Market Analysis
5.8.1 India Nivolumab Production
5.8.2 India Nivolumab Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Nivolumab Import and Export
6 Nivolumab Segment Market Analysis (by Type)
6.1 Global Nivolumab Production by Type
6.2 Global Nivolumab Revenue by Type
6.3 Nivolumab Price by Type
7 Nivolumab Segment Market Analysis (by Application)
7.1 Global Nivolumab Consumption by Application
7.2 Global Nivolumab Consumption Market Share by Application (2014-2019)
8 Nivolumab Major Manufacturers Analysis
8.1 Ono Pharmaceutical
8.1.1 Ono Pharmaceutical Nivolumab Production Sites and Area Served
8.1.2 Ono Pharmaceutical Product Introduction, Application and Specification
8.1.3 Ono Pharmaceutical Nivolumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb
8.2.1 Bristol-Myers Squibb Nivolumab Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Nivolumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
9 Development Trend of Analysis of Nivolumab Market
9.1 Global Nivolumab Market Trend Analysis
9.1.1 Global Nivolumab Market Size (Volume and Value) Forecast 2019-2025
9.2 Nivolumab Regional Market Trend
9.2.1 North America Nivolumab Forecast 2019-2025
9.2.2 Europe Nivolumab Forecast 2019-2025
9.2.3 China Nivolumab Forecast 2019-2025
9.2.4 Japan Nivolumab Forecast 2019-2025
9.2.5 Southeast Asia Nivolumab Forecast 2019-2025
9.2.6 India Nivolumab Forecast 2019-2025
9.3 Nivolumab Market Trend (Product Type)
9.4 Nivolumab Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Nivolumab Distributors List
10.3 Nivolumab Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Nivolumab
Table Global Nivolumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Nivolumab Production Market Share by Types in 2018
Figure Injection 4mL Product Picture
Figure Injection 10mL Product Picture
Table Global Nivolumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Nivolumab Consumption Market Share by Applications in 2018
Figure Unresectable Melanoma
Figure Metastatic Melanoma
Figure Metastatic Squamous NSCLC
Figure Classical Hodgkin Lymphoma
Figure Renal Cell Carcinoma
Figure Other
Figure Global Nivolumab Revenue (Million USD) (2014-2025)
Figure Global Nivolumab Production (K Pcs) (2014-2025)
Figure North America Nivolumab Market Size (Million USD) (2014-2025)
Figure Europe Nivolumab Market Size (Million USD) (2014-2025)
Figure China Nivolumab Market Size (Million USD) (2014-2025)
Figure Japan Nivolumab Market Size (Million USD) (2014-2025)
Figure Southeast Asia Nivolumab Market Size (Million USD) (2014-2025)
Figure India Nivolumab Market Size (Million USD) (2014-2025)
Table Nivolumab Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nivolumab in 2018
Figure Manufacturing Process Analysis of Nivolumab
Figure Industry Chain Structure of Nivolumab
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Nivolumab Manufacturing Plants Distribution
Table Nivolumab Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Nivolumab Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Nivolumab Production (K Pcs) of Major Manufacturers (2014-2019)
Table Nivolumab Production Market Share of Major Manufacturers (2014-2019)
Figure Nivolumab Production Share by Manufacturers in 2018
Table Nivolumab Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Nivolumab Revenue Market Share of Major Manufacturers (2014-2019)
Figure Nivolumab Revenue Share by Manufacturers in 2018
Table Nivolumab Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Nivolumab Production by Regions 2014-2019 (K Pcs)
Table Global Nivolumab Production Market Share by Regions 2014-2019
Figure Global Nivolumab Production Market Share by Regions in 2018
Table Global Nivolumab Revenue by Regions 2014-2019 (Million USD)
Table Global Nivolumab Revenue Market Share by Regions 2014-2019
Figure Global Nivolumab Revenue Market Share by Regions in 2018
Table Global Nivolumab Consumption by Regions 2014-2019 (K Pcs)
Table Global Nivolumab Consumption Market Share by Regions 2014-2019
Figure North America Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure North America Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table North America Nivolumab Production, Consumption Import and Export (K Pcs)
Figure Europe Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Nivolumab Production, Consumption Import and Export (K Pcs)
Figure China Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure China Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table China Nivolumab Production, Consumption Import and Export (K Pcs)
Figure Japan Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Nivolumab Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Nivolumab Production, Consumption Import and Export (K Pcs)
Figure India Nivolumab Production Growth Rate 2014-2019 (K Pcs)
Figure India Nivolumab Revenue Growth Rate 2014-2019 (Million USD)
Table India Nivolumab Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Nivolumab Market Share by Application (2014-2019)
Figure Global Value (Consumption) Nivolumab Market Share by Application (2014-2019)
Table Ono Pharmaceutical Nivolumab Production Sites and Area Served
Table Ono Pharmaceutical Nivolumab Product Introduction, Application and Specification
Table Ono Pharmaceutical Nivolumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ono Pharmaceutical Nivolumab Production Growth Rate (2014-2019)
Table Ono Pharmaceutical Nivolumab Production Market Share (2014-2019)
Figure Ono Pharmaceutical Nivolumab Revenue Market Share (2014-2019)
Table Ono Pharmaceutical Nivolumab Main Business and Markets Served
Table Bristol-Myers Squibb Nivolumab Production Sites and Area Served
Table Bristol-Myers Squibb Nivolumab Product Introduction, Application and Specification
Table Bristol-Myers Squibb Nivolumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Nivolumab Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Nivolumab Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Nivolumab Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Nivolumab Main Business and Markets Served
Figure Global Nivolumab Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Nivolumab Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Nivolumab Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Nivolumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Nivolumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Nivolumab by Type (2019-2025)
Table Global Consumption (K Pcs) of Nivolumab by Application (2019-2025)
Table Nivolumab Distributors List
Table Nivolumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非黒色腫皮膚癌の世界市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…- 黒色腫用薬の世界市場：インサイト・予測 Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of…
- ホジキンリンパ腫治療の世界市場：市場規模・現状・予測 Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- 世界のペンブロリズマブ市場：専門的調査 The global Pembrolizumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Pembrolizumab volume and value at global level, regional level and company level. From a global perspective, this r…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…